$528.00
▲ +0.2% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 25
▼ 0
How FBI Rapid DNA Approval Shapes Thermo Fisher Scientific’s (TMO) Long-Term Forensics Strategy
Thermo Fisher (TMO) Stock May Be Undervalued As Guidance Rises
Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS
Overview
52-week range
$385
$644
55% of range
Avg surprise (last 2)
+1.8%
Avg reaction (last 2)
+4.2%
50% positive
Latest IV / EM
98%
EM ±5.8% · $525 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Sat Mar 28, 2026 | Mar 2026 | $4.43 | — | — | — | — | financials |
| Sat Sep 27, 2025 | Sep 2025 | $4.27 | — | — | — | — | financials |
| Wed Jul 23, 2025 | Jun/2025 | $5.36 | $5.22 | +2.7% | — | +9.1% | earnings |
| Wed Apr 23, 2025 | Mar/2025 | $5.15 | $5.10 | +1.0% | — | -0.7% | earnings |
| Sat Sep 28, 2024 | Sep 2024 | $4.25 | — | — | — | — | financials |
| Sat Jun 29, 2024 | Jun 2024 | $4.04 | — | — | — | — | financials |
| Sat Mar 30, 2024 | Mar 2024 | $3.46 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $4.42 | — | — | — | — | financials |
| Sat Jul 1, 2023 | Jul 2023 | $3.51 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 23, 2026 | Jun/2026 | BMO | $5.71 | $5.36 | +6.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.86B | — | $1.94B | $1.83B | $1.72B | — | $1.84B | $1.82B |
| Net income | $1.65B | — | $1.62B | $1.62B | $1.51B | — | $1.63B | $1.55B |
| EPS (diluted) | $4.43 | — | $4.27 | $4.28 | $3.98 | — | $4.25 | $4.04 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.25B | $9.85B | $1.98B | $4.58B | $4.13B | $4.01B | $4.64B | $7.07B |
| Inventory | $5.50B | $5.42B | $5.75B | $5.56B | $5.22B | $4.98B | $5.43B | $5.20B |
| Total current assets | $22.32B | $28.71B | $22.30B | $24.58B | $23.38B | $22.14B | $23.78B | $25.48B |
| Total assets | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $51.93B | $53.41B | $51.02B | $50.51B | $49.39B | $49.58B | $48.99B | $47.43B |